[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.52.4. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 3, 1993

Metered-Dose Inhalers: Drug Delivery Over the Life of a Canister-Reply

JAMA. 1993;270(17):2051. doi:10.1001/jama.1993.03510170040017

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

In Reply.  —Since the time that AeroBid was approved in 1984, the requirements for its type of dose delivery system have been revised as our understanding of these medications has increased. Aerosolized steroid medications are currently required to demonstrate, among other properties, adequate puff-to-puff reproducibility over the claimed life of the canister.A frequent complexity that arises is the problem of the number of doses vs the number of actuations. The canisters are labeled with the number of actuations. Because a certain number of these are normally expended in the priming of the valve by the patient at the time of dosing, the number of actuations that are available for dosing is lower. Thus, a patient who takes two puffs twice a day theoretically could expect 25 days of medication from a 100-spray canister. However, if the unit is primed once a day, the duration drops to 20 days, and

×